“Examples of the former include … of the bioavailability of vitamin K by antibiotics, … oils or cholestyramine ; oestrogens, diuretics and hypolipidaemic agents such as clofibrate may influence vitamin K-dependent clotting factor synthesis, and drugs which affect haemostasis, e.g. via platelet function, will enhance the anticoagulant effect of warfarin.”